XML 56 R3.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Preference shares, par value $ 0.0001 $ 0.0001 $ 0.0001
Preference shares, shares authorized 5,000,000 5,000,000 5,000,000
Preference shares, shares issued 0 0 0
Preference shares, shares outstanding 0 0 0
Aspire Biopharma Inc [Member]      
Common shares, par value $ 0.01 $ 0.01 $ 0.01
Common stock, shares outstanding 443,000,000 443,000,000 443,000,000
Class A Ordinary Shares Subject To Possible Redemption [Member]      
Temporary equity, par value $ 0.0001 $ 0.0001 $ 0.0001
Temporary equity, shares outstanding 577,644 1,803,729 28,750,000
Common Class A [Member]      
Common shares, par value $ 0.0001 $ 0.0001 $ 0.0001
Common stock, shares authorized 300,000,000 300,000,000 300,000,000
Common stock, shares issued 7,187,500 7,187,500 0
Common stock, shares outstanding 7,187,500 7,187,500 0
Common Class A [Member] | Aspire Biopharma Inc [Member]      
Common shares, par value   $ 0.005 $ 0.005
Common Class B [Member]      
Common shares, par value $ 0.0001 $ 0.0001 $ 0.0001
Common stock, shares authorized 50,000,000 50,000,000 50,000,000
Common stock, shares issued 0 0 7,187,500
Common stock, shares outstanding 0 0 7,187,500